Hers Review

Hers — Provider Profile

Overview

Hers is the women's health brand from Hims & Hers Health (NYSE: HIMS), launched in 2019 as a companion to the men's-focused Hims platform. While Hims built its name on ED and hair loss treatments for men, Hers focuses on women's health — birth control, skincare, hair thinning, mental health, and weight management.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending; not yet in effect. Compounded semaglutide supply is declining under FDA enforcement pressure.

Here's the reality that matters for weight loss shoppers: the Hers and Hims GLP-1 programs are functionally identical. Same medications, same pricing, same provider network, same async consultation model. The difference is branding, packaging, and the broader product catalog. A woman could use Hims for GLP-1s and receive the exact same program — but Hers wraps it in a women's health context with content addressing hormonal weight gain, postpartum weight, and menopause-related metabolic changes.

As a publicly traded company with over $1 billion in annual revenue, Hers operates at a scale that most telehealth startups cannot match. That scale enables competitive pricing and rapid fulfillment — but it also means you're getting a high-volume, efficiency-optimized experience rather than personalized clinical depth.

Pricing and protocol data sourced from this provider's public website, verified April 2026. Patient experience data from verified patient reports. We have no commercial relationship with this provider.

Medications Offered

• Compounded semaglutide (injectable) — GLP-1 receptor agonist via 503B-registered outsourcing facilities
• Compounded oral semaglutide — Available for patients who prefer tablets over injections
• Brand Wegovy (semaglutide) — FDA-approved for chronic weight management
• Brand Wegovy HD (semaglutide 7.2mg) — Higher-dose Wegovy formulation, weekly subcutaneous injection
• Brand Zepbound (tirzepatide) — Dual GIP/GLP-1 receptor agonist, $399/mo

Hers does not offer compounded tirzepatide or non-GLP-1 weight loss medications (unlike Mochi Health or Found, which offer broader medication selections).

Regulatory note: The Hims & Hers compounded semaglutide program has faced significant regulatory uncertainty. When the FDA declared the national semaglutide shortage resolved in early 2025, it removed the legal exemption that allowed compounders to produce semaglutide copies. Hims & Hers pursued legal action to continue offering compounded options. Availability may change — check forhers.com for current medication offerings.

Pricing

Pricing last verified April 2026. Confirm current pricing directly with the provider before enrolling.

No separate membership fee. The monthly price is all-inclusive — provider access, medication, and free shipping. This is simpler than Mochi Health's two-part pricing (membership + medication) or Amazon One Medical's membership + separate medication cost.

The $199/mo compounded semaglutide price is slightly higher than Ro ($149) and Henry Meds ($149), but Hers includes compounded oral semaglutide tablets as an alternative for patients who want to avoid injections — a relatively unique offering among major telehealth providers.

States Served

Available in most US states. Compounded medication availability may be restricted in certain states due to pharmacy board regulations. Virtual consultations are available broadly. Check forhers.com for current state-by-state availability.

Insurance

• Consultations: Included in the medication subscription — no separate consultation fee
• Brand-name GLP-1s: Available through insurance with prior authorization
• Compounded medications: Cash-pay only (standard across the telehealth industry)
• HSA/FSA: Eligible for weight loss program payments

Consultation Process

Model: Async only — no video or phone consultations for the weight loss program.

1. Complete an online health assessment covering medical history, current medications, BMI, and weight loss goals
2. A licensed provider reviews your submission asynchronously (typically within 24–48 hours)
3. If approved, medication ships directly to your door in 3–5 business days
4. Ongoing messaging access to your care team through the Hers app
5. Monthly check-ins and refill management through the platform

The async model is efficient — most patients go from sign-up to medication in under a week. But you will never speak with a provider face-to-face. For patients who want clinical guidance, this is a significant limitation.

Pros

• Clean, women-focused branding and content on hormonal weight management, postpartum weight, and menopause
• Competitive pricing at $199/mo all-in, no hidden membership fees
• Compounded oral semaglutide available — unusual option for needle-averse patients
• Fast process — prescription often within 24–48 hours
• Backed by a publicly traded company (NYSE: HIMS) — financial transparency and regulatory oversight
• Free shipping included
• No long-term contracts — cancel anytime

Cons

• Async-only consultations — no video or phone calls with providers
• GLP-1 program is identical to Hims — the women's branding is the only differentiation
• No compounded tirzepatide option
• No lifestyle coaching, nutrition guidance, or behavioral support (unlike Calibrate, Found, or WeightWatchers Clinic)
• Compounded semaglutide availability subject to ongoing FDA regulatory action
• More expensive than Ro ($149) and Henry Meds ($149) for compounded semaglutide
• Limited medication selection — no non-GLP-1 weight loss alternatives

Hers vs Hims: What's Actually Different?

For weight loss specifically, very little:

If you're choosing between Hers and Hims purely for GLP-1 weight loss, the decision comes down to which branding resonates more. The clinical experience is identical. For a full breakdown, see our Hers vs Hims weight loss comparison.

Who Is Hers Best For?

Ideal for:

• Women who prefer a women's health–focused telehealth experience
• Patients seeking compounded semaglutide at a predictable monthly price
• Needle-averse patients interested in compounded oral semaglutide tablets
• People who value convenience and fast turnaround over clinical depth

Not ideal for:

• Patients who want video consultations or in-person care
• Women seeking integrated lifestyle coaching alongside medication
• Patients who need tirzepatide (compounded or brand) at an affordable price
• Those with complex medical histories that benefit from more clinical oversight

The Bottom Line

Hers provides the same GLP-1 weight loss program as Hims, repackaged for a women's health audience. The $199/mo compounded semaglutide offering is competitively priced and the async model is convenient, but there's no clinical differentiation from the men's platform. If you value women-focused branding and content, Hers delivers that. If you're comparing on price, medications, or clinical depth, evaluate Hers against the broader telehealth market — not just against Hims.

Data Sources

Pricing and protocol information sourced from Hers's official website (verified April 2026). Consultation process details sourced from provider onboarding flow documentation. Patient experience descriptions sourced from public patient reviews. Telehealth Ally has no affiliate or commercial relationship with this provider.

Related Content

• Hers vs Hims Weight Loss — Are they actually different?
• Hims Provider Profile — The men's-focused sister platform
• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Cost & Insurance FAQ — What you'll actually pay
• Semaglutide Dosing Guide — Every formulation, every dose step

Pricing and availability current as of April 2026. Hers is a brand of Hims & Hers Health, Inc. (NYSE: HIMS). Telehealth Ally is not affiliated with Hims & Hers Health.